Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gabapentin for quadriceps weakness after ACL reconstruction
NCT03496389Phase 3Unknown
- Sponsor
- Hospital Authority
- Start
- Jul 2018
- Primary completion
- Jul 2019
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of gabapentin in muscle weakness, sponsored by Hospital Authority. Status: unknown.
02
Drugs
gabapentin
03
Conditions
muscle weakness
Beyond the preview
Go deeper on NCT03496389.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03496389.